Framler
Signal Feed
WatchlistTrack Record
⌕
LIVE
Framler · © 2026
Engine
MethodologySectorsPatternsCompareAlternativesScreenersGlossaryTrack RecordSleeve P&LShort SqueezeTop Rated
Research moat
MoatResearchCase Study: NVDA
Company
InvestorsPressBlogChangelogRoadmapAPIAboutContact
FEATURED ANALYSISNVDATSLAAAPLAMDMSFTMETA
Framler is a quantitative research platform - not a broker, investment advisor, or fiduciary. Nothing on this site constitutes a recommendation to buy, sell, or hold any security. All model outputs - scores, verdicts, intervals, predictions - are for informational and educational purposes only. Past performance does not guarantee future results. Invest at your own risk. Built on public data - SEC EDGAR, ClinicalTrials.gov, PubMed, Yahoo Finance, Finnhub, FMP.
TRUSTThe BetLedgerStatusSecurity·LEGALTermsPrivacyDisclaimer
AbbVie Inc. (ABBV) company logo
Healthcare · NYSE
Calibration 4/4:●1d●7d●30d●90d

ABBV STOCK · AbbVie Inc. BullishMulti-factor aligned

$261.83-1.56%
~1-month outlook, not a day-trade. The score updates daily as the data changes — re-check weekly rather than reacting to a single day's move.
66
◐Sector calibration · noisy
Engine accuracy in Healthcare has been close to zero on recent rolling windows. Treat the composite as informational. Lean on Confluence patterns, Insider clustering, and Options flow — sub-signals that retain edge in narrative-driven cohorts.
AgreementMODERATE ALIGNMENT

Some factor streams agree, others diverge.

90% interval: [16–95]Top driver: Sector Spillover
PATTERN HISTORY · 14Dhit rate 55.6%mean ret +1.18%n=4719Measured across every ticker that fired this setup — not this stock's own history.
OutlookTop decile — strong factor setup for this regime🔒 Sign in for number

Why ABBV scores 66

  • +Sector in favour — rotation tailwind
  • +Adjacent industry leaders rallying (Cohen-Frazzini)
  • +Clean accruals — earnings backed by cash (Sloan)

Full report — sign in to unlock

🧬 Phase 3 / FDA catalyst

ABBV has an active Phase 3 clinical trial — NCT06810505. Framler models the failure probability for ABBV from ClinicalTrials.gov data — the figure is shown after you sign in.

🧬 Biotech intelligence
Bayesian Phase-3 trial failure probability vs the disease base rate, an estimated FDA decision window, patent-cliff timing, and comparable historical trials — the biotech layer for ABBV.
🔒 Sign up to unlock →
🔒 Forward-Return Projection

Expected returns over 1 / 7 / 30 / 90 days with 90% confidence intervals, regime amplifier, pattern multiplier, copula tail-dependence — composed into one Bayesian distribution.

🔒 Full Factor Breakdown

Per-factor 0-100 scores across quality, value, momentum, PEAD, accruals, insider flow, NLP tone, options flow, short interest, sector momentum, factor interaction — plus the score waterfall.

🔒 Confluence Patterns

Active multi-factor patterns (QUALITY COMPOUNDER, VALUE TRAP, SHORT SQUEEZE, OVEREXTENDED, etc.) with academic basis and pattern delta against the raw composite.

🔒 Plain-English Explanation & Scenarios

Plain-English read of what the engine sees on this ticker today + what-if scenarios (price ±N%, regime flip, shock) replayed through the deterministic engine. No AI in the scoring path.

Unlock the full ABBV report
Free during early access · no credit card · 1,000+ stocks tracked daily
Sign up free →
How is this score built?Methodology →24 patterns →Research paper →Sector rotation →Track record →Glossary →Math coherence →

Were we right on ABBV? — 90 graded days

WE MADE A CALL ON 34 OF 90 DAYS — RIGHT 23 · WRONG 11
-5%0%+5%+10%+15%2026-04-09: we said UP (score 60), stock went -1.23% over the next 7 days — WRONG2026-04-10: no call (score 58) — stock went -1.52% over the next 7 days2026-04-13: no call (score 42) — stock went -2.03% over the next 7 days2026-04-14: no call (score 42) — stock went -1.36% over the next 7 days2026-04-15: no call (score 47) — stock went -2.89% over the next 7 days2026-04-16: no call (score 57) — stock went -4.43% over the next 7 days2026-04-17: no call (score 51) — stock went -4.92% over the next 7 days2026-04-20: no call (score 49) — stock went -5.28% over the next 7 days
factor
🔒 Insider Flow & News Grid

90-day net SEC Form 4 dollar flow with size normalisation, plus filtered news headlines clustered by topic.

🔒 Watchlist & Virtual Trades

Add to watchlist for daily score alerts; place a paper trade with the engine's confidence dial frozen at entry; track P&L over 30 / 90 / 180 days against the verdict horizon.

2026-04-21: no call (score 46) — stock went -2.96% over the next 7 days2026-04-22: no call (score 55) — stock went -0.60% over the next 7 days2026-04-23: no call (score 51) — stock went +5.40% over the next 7 days2026-04-24: we said UP (score 80), stock went +2.81% over the next 7 days — RIGHT2026-04-27: we said UP (score 73), stock went +4.76% over the next 7 days — RIGHT2026-04-28: we said UP (score 73), stock went +4.42% over the next 7 days — RIGHT2026-04-29: we said UP (score 73), stock went +3.71% over the next 7 days — RIGHT2026-04-30: we said UP (score 74), stock went -0.58% over the next 7 days — WRONG2026-05-01: no call (score 55) — stock went -4.62% over the next 7 days2026-05-04: no call (score 49) — stock went -1.85% over the next 7 days2026-05-05: no call (score 53) — stock went +0.85% over the next 7 days2026-05-06: no call (score 51) — stock went +1.16% over the next 7 days2026-05-07: no call (score 56) — stock went +2.80% over the next 7 days2026-05-08: no call (score 45) — stock went +3.79% over the next 7 days2026-05-11: we said UP (score 70), stock went +2.77% over the next 7 days — RIGHT2026-05-12: we said UP (score 70), stock went +5.41% over the next 7 days — RIGHT2026-05-13: no call (score 56) — stock went +2.46% over the next 7 days2026-05-14: no call (score 57) — stock went +2.88% over the next 7 days2026-05-15: we said UP (score 71), stock went +2.34% over the next 7 days — RIGHT2026-05-18: we said UP (score 72), stock went +1.30% over the next 7 days — RIGHT2026-05-19: we said UP (score 60), stock went +1.77% over the next 7 days — RIGHT2026-05-20: no call (score 56) — stock went +0.77% over the next 7 days2026-05-21: no call (score 59) — stock went +2.98% over the next 7 days2026-05-22: no call (score 57) — stock went +1.50% over the next 7 days2026-05-25: no call (score 44) — stock went -1.28% over the next 7 days2026-05-26: no call (score 44) — stock went -0.14% over the next 7 days2026-05-27: no call (score 44) — stock went +1.88% over the next 7 days2026-05-28: no call (score 57) — stock went +4.43% over the next 7 days2026-05-29: no call (score 55) — stock went +3.93% over the next 7 days2026-06-01: no call (score 59) — stock went +2.46% over the next 7 days2026-06-02: we said UP (score 69), stock went +5.87% over the next 7 days — RIGHT2026-06-03: no call (score 57) — stock went +4.43% over the next 7 days2026-06-04: no call (score 55) — stock went +3.52% over the next 7 days2026-06-05: no call (score 55) — stock went +1.24% over the next 7 days2026-06-08: no call (score 59) — stock went -2.48% over the next 7 days2026-06-09: we said UP (score 60), stock went -0.27% over the next 7 days — WRONG2026-06-10: no call (score 57) — stock went -1.86% over the next 7 days2026-06-11: we said UP (score 61), stock went -3.76% over the next 7 days — WRONG2026-06-12: we said UP (score 62), stock went +2.33% over the next 7 days — RIGHT2026-06-15: no call (score 57) — stock went +1.00% over the next 7 days2026-06-16: no call (score 58) — stock went +5.94% over the next 7 days2026-06-17: no call (score 55) — stock went +5.58% over the next 7 days2026-06-18: no call (score 57) — stock went +9.90% over the next 7 days2026-06-19: we said UP (score 61), stock went +17.03% over the next 7 days — RIGHT2026-06-22: no call (score 58) — stock went +17.47% over the next 7 days2026-06-23: no call (score 55) — stock went +9.40% over the next 7 days2026-06-24: no call (score 58) — stock went +6.94% over the next 7 days2026-06-25: we said UP (score 60), stock went +11.15% over the next 7 days — RIGHT2026-06-26: no call (score 57) — stock went +4.78% over the next 7 days2026-06-29: no call (score 58) — stock went +0.56% over the next 7 days2026-06-30: no call (score 58) — stock went +0.13% over the next 7 days2026-07-01: we said UP (score 61), stock went +0.44% over the next 7 days — RIGHT2026-07-02: we said UP (score 60), stock went -0.46% over the next 7 days — WRONG2026-07-03: no call (score 57) — stock went -4.98% over the next 7 days2026-07-06: no call (score 58) — stock went -5.01% over the next 7 days2026-07-07: no call (score 57) — stock went -3.92% over the next 7 days2026-07-08: no call (score 56) — stock went -3.64% over the next 7 days2026-07-09: we said UP (score 62), stock went +0.65% over the next 7 days — RIGHT2026-07-10: we said UP (score 60), stock went +1.83% over the next 7 days — RIGHT2026-07-13: we said UP (score 62), stock went +2.14% over the next 7 days — RIGHT2026-07-14: we said UP (score 61), stock went +3.27% over the next 7 days — RIGHT2026-07-15: we said UP (score 60), stock went +3.48% over the next 7 days — RIGHT2026-07-16: no call (score 59) — stock went +5.25% over the next 7 days2026-07-17: we said UP (score 60), stock went +1.95% over the next 7 days — RIGHT2026-07-20: no call (score 50) — stock went +0.95% over the next 7 days2026-07-21: we said UP (score 63), stock went +3.88% over the next 7 days — RIGHT2026-07-22: no call (score 58) — stock went +2.81% over the next 7 days2026-07-23: we said UP (score 69), stock went +1.62% over the next 7 days — RIGHT2026-07-24: no call (score 57) — stock went -2.33% over the next 7 days2026-07-27: no call (score 59) — stock went -5.50% over the next 7 days2026-07-28: we said UP (score 62), stock went -5.10% over the next 7 days — WRONG2026-07-29: we said UP (score 60), stock went -6.46% over the next 7 days — WRONG2026-07-30: we said UP (score 62), stock went -7.38% over the next 7 days — WRONG2026-07-31: no call (score 58) — stock went -4.42% over the next 7 days2026-08-03: no call (score 51) — stock went -1.18% over the next 7 days2026-08-04: no call (score 57) — stock went +2.04% over the next 7 days2026-08-05: we said DOWN (score 37), stock went +2.03% over the next 7 days — WRONG2026-08-06: no call (score 42) — stock went +1.88% over the next 7 days2026-08-07: we said DOWN (score 37), stock went +2.29% over the next 7 days — WRONG2026-08-10: no call (score 41) — stock went +1.74% over the next 7 days2026-08-11: we said DOWN (score 37), stock went +4.42% over the next 7 days — WRONG2026-08-12: we said UP (score 67), stock went +6.35% over the next 7 days — RIGHTApr 9Aug 12
we made a call and were rightwe made a call and were wrongno call that day

Each bar is what ABBV actually did over the 7 days after one of our published scores — up bars, the stock rose; down bars, it fell. A “call” is a day the score left the middle zone (above 60 = we said up, below 40 = we said down), and it's counted right only if the stock then moved our way. Faint bars are days we made no call — saying “we don't know” is allowed here. These are raw counts on one stock, far too few to prove skill either way — the serious, pre-registered test across all 1,001 stocks is the public bet.